Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression

por Haynes, Katelin R., Tseng, Hsu-Wen, Kneissel, Michaela, Glant, Tibor T., Brown, Matthew A., Thomas, Gethin P.
Publicado 2015

Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors

por Haynes, Katelin R, Pettit, Allison R, Duan, Ran, Tseng, Hsu-Wen, Glant, Tibor T, Brown, Matthew A, Thomas, Gethin P
Publicado 2012